IT-901 | m-entrepreneurship.com

Product Name :
IT-901

Search keywords :
IT-901

drugId :
null

Target Vo:
Proto-oncogene c-Rel

Target Vo Short Name :
REL

Moa_Name:
Proto-oncogene c-Rel inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
ImmuneTarget Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Lilotomab Protocol
Lamin B1 Rabbit mAb Autophagy
Phospho-Met Antibody (YA175): Phospho-Met Antibody (YA175) is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Phospho-Met (pY1349). It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts